Rape FIR against pharma firm CMD after HC order
Source: Times Of India The Ahmedabad police on Sunday booked the CMD of a major pharmaceutical company in the state for rape following the Gujarat HC’s order on allegations levelled by a Bulgarian woman. ACP H M Kansagra said, “Complying with the court order, we filed a complaint on Sunday against Cadila Pharmaceuticals CMD Rajiv […]
Indian pharma firm launches oral solution for prostrate cancer
BDR Pharmaceuticals on Tuesday launched an oral solution in 32mg/mL designed for the management of prostate cancer. According to a press statement, BDENZA will be available at Rs. 27,000 for 150mL. “This innovative formulation marks a significant step forward in providing an effective dosage form, with lesser side effects in comparison to existing oral dosage forms […]
Fake medicines racket busted in Hyderabad
Source: Thenewsminute A spurious drugs racket of fake antibiotics, painkillers, and hypertension and cholesterol medicines labelled with the names of reputed pharma companies was unearthed in Hyderabad, officials said. Telangana Drugs Control Administration unearthed a spurious medicines racket of fake antibiotics, hypertension and cholesterol medicines, analgesics in Hyderabad. The raids were conducted at various locations […]
‘Upgrade Quality or Risk Shutdowns’, DCGI
Source: News18 India’s pharmaceutical industry has undergone a comprehensive regulatory overhaul spearheaded by the nation’s apex health regulatory agency and its chief, the Drug Controller General of India (DCGI), amid quality concerns raised by global regulators. Throughout the year, DCGI Rajeev Singh Raghuvanshi made headlines for his several moves, ranging from aggressive raids on pharmaceutical […]
The 10 Biggest Trends Revolutionizing Healthcare In 2024
Source: Forbes A longer-living population, the emergence of transformative technologies with applications across the healthcare spectrum, and continued global economic uncertainty. These are the key societal drivers that will impact healthcare in 2024. Their convergence means we are heading into uncharted waters. On the technology side, artificial intelligence (AI) promises to dramatically change everything from […]
Cell, gene therapy to rule pharmaceutical sector in 2024: Report
Source: Mid Day The report by GlobalData, a data and analytics company, is based on a survey of 115 healthcare industry professionals. It revealed that 18 per cent of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year. This was followed by personalised/precision medicine (16 per cent). […]
Barcode solution role in pharma serialisation: Ensuring medication safety
Source: Hindustan Times As technology advances and regulatory scrutiny intensifies, it is critical to ensure the safety and authenticity of pharmaceutical products across the supply chain. Adherence to serialisation compliance standards is becoming a global standard, and this is especially important for India, a significant exporter to global markets dealing with expanding domestic compliances. Additionally, […]
3 employees booked for duping Ludhiana pharma firm of ₹5.5 crore
Source: Business Standard At least three employees of a pharmaceutical company have been booked for cheating and causing ₹5.47 crore losses to their employer. The accused allegedly took orders from other companies and supplied medicines without knowledge of the employer. The Sarabha Nagar police booked Sarojit Rao of Heerapur in Jharkhand, Ankur Kumar of Purnia in […]
Pharma lobby bats for drug approvals in India to align with global markets
Source: Business Standards To hasten the launch of new medicines in India, the Organisation of Pharmaceutical Producers of India (OPPI), which represents key multinational pharmaceutical companies, has urged the drug controller to enable parallel approval of drugs in sync with global markets, reported The Economic Times (ET). According to the OPPI, launching a new drug in […]
AstraZeneca Pharma to launch breast cancer drug, shares jump
Source: Money Control AstraZeneca Pharma shares gained 6 percent intraday on December 21 after the pharma company said it will launch Enhertu, a breast cancer drug, in January 2024 in India. “Enhertu is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received a prior anti-HER2-based regimen,” said […]